Total Payments
$19,798
2024 Payments
$1,074
Companies
50
Transactions
568
Medicare Patients
4,777
Medicare Billing
$238,060
Payment Breakdown by Category
Food & Beverage$12,576 (63.5%)
Other$6,000 (30.3%)
Travel$1,140 (5.8%)
Education$82.31 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,576 | 550 | 63.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,000 | 1 | 30.3% |
| Travel and Lodging | $1,140 | 6 | 5.8% |
| Education | $82.31 | 11 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $7,575 | 28 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,220 | 60 | $0 (2024) |
| Abbott Laboratories | $1,110 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,094 | 74 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $964.83 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $767.90 | 38 | $0 (2024) |
| ABIOMED | $730.97 | 30 | $0 (2023) |
| Amgen Inc. | $701.62 | 42 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $681.59 | 29 | $0 (2024) |
| ATRICURE, INC. | $636.97 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,074 | 43 | Abbott Laboratories ($233.31) |
| 2023 | $1,758 | 80 | Boehringer Ingelheim Pharmaceuticals, Inc. ($245.58) |
| 2022 | $1,706 | 66 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($231.05) |
| 2021 | $1,283 | 24 | ATRICURE, INC. ($636.97) |
| 2020 | $7,266 | 15 | Amarin Pharma Inc. ($6,993) |
| 2019 | $2,657 | 126 | SANOFI-AVENTIS U.S. LLC ($495.23) |
| 2018 | $1,977 | 100 | Amarin Pharma Inc. ($285.40) |
| 2017 | $2,078 | 114 | Novartis Pharmaceuticals Corporation ($313.37) |
All Payment Transactions
568 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.65 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/20/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $38.46 | General |
| Category: Transcatheter Valve Systems | ||||||
| 08/14/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Transcatheter Valve Systems | ||||||
| 08/06/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Cardiology | ||||||
| 07/24/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Transcatheter Valve Systems | ||||||
| 07/11/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $154.65 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: Not Applicable | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Transcatheter Valve Systems | ||||||
| 05/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/15/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Cardiac Rhythm Management | ||||||
| 05/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardiology | ||||||
| 05/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiology | ||||||
| 04/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: Cardiovascular | ||||||
| 04/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: DIABETES | ||||||
| 04/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Cardiac Rhythm Management | ||||||
| 04/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $30.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,183 | 2,832 | $257,372 | $87,474 |
| 2022 | 19 | 1,473 | 1,798 | $246,657 | $84,434 |
| 2021 | 18 | 856 | 990 | $160,398 | $58,914 |
| 2020 | 7 | 265 | 280 | $37,289 | $7,238 |
Total Patients
4,777
Total Services
5,900
Medicare Billing
$238,060
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 364 | $74,984 | $33,431 | 44.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,152 | 1,527 | $41,229 | $9,457 | 22.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 173 | 175 | $35,875 | $8,586 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $19,520 | $7,385 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 34 | $9,452 | $4,749 | 50.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 51 | $10,302 | $4,583 | 44.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 259 | 336 | $20,160 | $3,639 | 18.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 55 | $7,755 | $3,325 | 42.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $7,504 | $2,554 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 37 | $5,143 | $2,315 | 45.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 36 | 36 | $8,496 | $2,076 | 24.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $4,776 | $2,010 | 42.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,704 | $1,163 | 43.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 23 | 23 | $4,715 | $1,138 | 24.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 44 | 44 | $2,068 | $472.11 | 22.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 23 | 23 | $1,610 | $375.03 | 23.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 13 | 13 | $1,079 | $214.50 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 345 | $71,070 | $32,752 | 46.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 84 | 84 | $26,880 | $9,446 | 35.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 163 | 163 | $33,906 | $8,464 | 25.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 44 | 62 | $12,524 | $4,839 | 38.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 227 | 307 | $18,420 | $3,303 | 17.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 59 | $8,319 | $3,246 | 39.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 25 | $6,950 | $3,199 | 46.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 41 | 41 | $8,118 | $3,112 | 38.3% |
About Dr. Jerry Gilbert, MD
Dr. Jerry Gilbert, MD is a Cardiovascular Disease healthcare provider based in College Station, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629079017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerry Gilbert, MD has received a total of $19,798 in payments from pharmaceutical and medical device companies, with $1,074 received in 2024. These payments were reported across 568 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($12,576).
As a Medicare-enrolled provider, Gilbert has provided services to 4,777 Medicare beneficiaries, totaling 5,900 services with total Medicare billing of $238,060. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Interventional Cardiology
- Location College Station, TX
- Active Since 08/09/2005
- Last Updated 12/11/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1629079017
Products in Payments
- Vascepa (Drug) $7,575
- LifeVest (Device) $1,220
- XARELTO (Drug) $1,094
- ELIQUIS (Drug) $805.28
- Impella (Device) $730.97
- JARDIANCE (Drug) $697.50
- ENTRESTO (Drug) $630.67
- SYNERGY ABLATION SYSTEM (Device) $465.58
- Repatha (Biological) $464.63
- BRILINTA (Drug) $354.37
- GALLANT (Device) $324.57
- PRALUENT (Drug) $320.20
- CoreValve Evolut (Device) $289.85
- PRADAXA (Drug) $267.33
- DISEASE STATE (Drug) $248.42
- Corlanor (Drug) $226.99
- CHANTIX (Drug) $199.72
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $149.78
- Livalo (Drug) $143.47
- COREVALVE EVOLUT R (Device) $142.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in College Station
Mario Lammoglia, M.d, M.D
Cardiovascular Disease — Payments: $20,364
Cardiovascular Disease $20,364
Charles Howard, Md, MD
Cardiovascular Disease — Payments: $14,902
Cardiovascular Disease $14,902
Dr. Adnan Khalid, Md, MD
Cardiovascular Disease — Payments: $12,494
Cardiovascular Disease $12,494
Dr. Curtis Stauffer, M.d, M.D
Cardiovascular Disease — Payments: $3,197
Cardiovascular Disease $3,197
Dr. Daniel Larsen, M.d, M.D
Cardiovascular Disease — Payments: $2,584
Cardiovascular Disease $2,584
Dr. Biyebelemo Ekpete, D.o, D.O
Cardiovascular Disease — Payments: $2,097
Cardiovascular Disease $2,097